Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class II · Moderate risk

Lidocaine Hydrochloride Topical Solution USP 4%

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Ongoing Stability / shelf life McKesson Corporation dba McKesson Drug Company NDC 63739-977-64 D-0848-2022
Class II · Moderate risk

Halobetasol Propionate Ointment 0.05% Net Wt.

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.

Ongoing Stability / shelf life McKesson Corporation dba McKesson Drug Company NDC 63739-998-67 D-0847-2022
Class II · Moderate risk

Torco Racing Fuels Hand Sanitizer

CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Terminated cGMP deviation Torco Race Fuels D-0786-2022
Class I · High risk

Tacrolimus

Subpotent drug

Terminated Wrong potency / content Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy D-1168-2022
Class I · High risk

Tacrolimus

Subpotent drug

Terminated Wrong potency / content Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy D-1167-2022
Class III · Low risk

Phenobarbital Elixir

Does Not Meet USP or OTC Monograph: Product exceeds USP specification for alcohol content

Terminated Unapproved drug Monarch PCM, LLC NDC 69367-172-16 D-0878-2022
Class II · Moderate risk

Intralipid

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0338-0519-58 D-1120-2022
Class II · Moderate risk

Intralipid

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0338-0519-09 D-1119-2022
Class II · Moderate risk

Diprivan (Propofol)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 63323-269-29 D-1116-2022
Class II · Moderate risk

Diprivan (Propofol)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 63323-269-10 D-1115-2022

Recalls by year